For Journalists


For Journalists



NIH Grant To Aid Researchers In Developing Artificial Heart

January 28, 2000 -- Heart disease is America's top killer, claiming more than 400,000 lives each year. The most severely affected patients could be saved by new hearts, but only 3,000 or so heart transplants are performed each year. That leaves a number of seriously ill patients -- estimates range from 17,000 to 240,000 annually -- who could live long, productive lives if reliable artificial hearts were available.

Paul Allaire, a University of Virginia professor of mechanical engineering, and his colleagues at U.Va. and in Utah are working to develop such an artificial heart.

Allaire and his associates have received a grant of nearly $4.2 million from the National Institutes of Health to continue development of an artificial heart pump. This new grant provides funding after an earlier, $3 million research grant from InterMountain Health Care, a not-for-profit corporation that runs a hospital system in Utah, ended last month.

The new grant will be split between Allaire's group at U.Va., which is refining the mechanical aspects of the pump, and the Utah Artificial Heart Institute, an independent research center in Salt Lake City whose principals include cardiologists formerly associated with the University of Utah.

Dr. Don B. Olsen, president of the Heart Institute, notes that the grant will cover about half the cost of developing the current prototype into a model ready for clinical trials. MedQuest Products Inc., a medical device company also located in Salt Lake City, has agreed to raise the other half of development costs.

The technology is protected by pending patents held by the University of Virginia Patent Foundation.

Utah's researchers are internationally known for their work in artificial heart development and cardiac surgery. It was at the University of Utah in 1982 that the Jarvik-7 artificial heart was implanted in Barney Clark, the world's first recipient of a "permanent" artificial heart.

Currently, some patients receive artificial, "bridge-to-transplant," hearts. These grapefruit-sized devices enable patients to survive, in bed, for six months to a year, waiting for a compatible human heart to be found. But these artificial hearts are only a temporary solution. No "permanent" (that is, offering a life of 10 to 20 years) artificial hearts have been approved for routine use by the U.S. Food and Drug Administration, which regulates medical devices.

In a previous prototype of an artificial heart, Utah researchers had used ball bearings to operate the propeller-like "impeller," or rotating blade, that moved the blood through the pump. But the ball bearings damaged the red blood cells. So, the Utah team sought to create a new prototype that used magnetic bearings, which would allow the impeller to be suspended in the blood flow, reducing friction and eliminating damage to the blood cells. In 1991, the Utah artificial heart researchers sought Allaire's expertise at the Center for Magnetic Bearings, at U.Va.'s School of Engineering and Applied Science.

Researchers wanted to reduce the number of moving parts thereby minimizing the chances for mechanical failure. Current pulsating heart pumps have more than 100 moving parts and associated reliability problems. They typically last one to two years before malfunctioning, according to Allaire. In contrast, the U.Va.-Utah prototype has only one moving part -- the pump impeller -- boosting the device's expected lifetime to more than 10 years, he said.

The simple, circular design of the inside of the pump and a single moving part, the impeller, also minimize the chance of thrombosis, or potentially fatal blood clotting, according to Allaire.

The U.Va.-Utah team's current prototype, the CF-4 or "HeartQuest," will probably be made of some type of plastic, to make it as lightweight as possible, and operated by eight electro-magnets, Allaire said. A hollowed-out interior will hold the impeller, a lightly fluted, concave disk that will spin on a center pin at about 3,000 rpm. Heart patients with the devices would wear external batteries in a vest to supply the necessary power.

The previous prototype, CFVAD-3 (Continuous Flow Ventricular Assist Device), was essentially the shape and size of a hockey puck, made of rust-resistant titanium and weighing about three pounds. An even earlier version, the CFVAD2, weighed about 15 pounds and was about 4 inches by 7 inches.

The U.Va. engineers have yet another experimental version of the heart pump on the drawing board, the CF-5, which will use permanent magnets instead of electromagnets and require even less power to operate.

The U.Va. team will devote its share of the grant to covering the costs of testing the model now under development and building new, smaller, and more sophisticated prototypes of the heart-assist devices.

For more information contact Paul Allaire at (804) 924-6209, or at

Contact: Charlotte Crystal, (804) 924-6858

FOR ADDITIONAL INFORMATION: please contact the Office of University Relations at (804) 924-7116. Television reporters should contact the TV News Office at (804) 924-7550.
SOURCE: U.Va. News Services


UVa News Sources UVa Top News UVa WebCalendar UVa Home Page UVa News Sources UVa Top News UVa WebCalendar UVa Home Page

Top news site edited by Jane Ford (; maintained by Karen Asher (; releases posted by Suzanne Raileanu (
Last Modified: Monday, 14-Feb-2000 15:32:15 EST
© 2000 by the Rector and Visitors of the University of Virginia
Topnews Information: (804) 924-4298.

News Sources UVa WebCalendar UVa Home Page News Sources UVa WebCalendar UVa Home Page UVa Top News UVa WebCalendar UVa Home Page UVa Top News UVa WebCalendar UVa Home Page UVa News Sources UVa Top News UVa WebCalendar UVa Home Page UVa News Sources UVa Top News UVa WebCalendar Uva Home Page